Nuzenio

Regulatory Milestones Tipranks

Regulatory Milestones Tipranks news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Silexion Updates SIL204 Clinical and Regulatory Roadmap - TipRanksTipRanks · Mon, 10 Aug 2026 11:01:11 GMTElutia Receives Nasdaq Notice on Listing Compliance Risk - The Globe and MailThe Globe and Mail · Sat, 08 Aug 2026 21:08:00 GMTExelixis Earnings Call: Cabo Strength, Zanza Awaited - TipRanksTipRanks · Sat, 08 Aug 2026 00:24:20 GMTOcugen: Buy Rating Reaffirmed as Cash Runway Extends to 2028 and Ophthalmology Pipeline Advances; $11 Price Target Maintained - TipRanksTipRanks · Fri, 07 Aug 2026 23:25:43 GMTNatera Earns Buy Rating on Surging Signatera Demand, Raised Revenue Outlook, and Multi‑Year Growth Visibility - TipRanksTipRanks · Fri, 07 Aug 2026 18:01:20 GMTCullinan Maintained at Buy as Rich Clinical Pipeline and Regulatory Momentum Support Unchanged $33 Price Target - TipRanksTipRanks · Fri, 07 Aug 2026 17:29:38 GMTSpectral Medical Hits Regulatory Milestone on PMX as Financing and Commercial Plans Advance - TipRanksTipRanks · Fri, 07 Aug 2026 15:42:41 GMTNatera price target raised to $320 from $290 at BTIG - TipRanksTipRanks · Fri, 07 Aug 2026 10:58:39 GMT

Timeline

Mon, 10 Aug 2026 11:01:11 GMTSilexion Updates SIL204 Clinical and Regulatory Roadmap - TipRanks
Sat, 08 Aug 2026 21:08:00 GMTElutia Receives Nasdaq Notice on Listing Compliance Risk - The Globe and Mail
Sat, 08 Aug 2026 00:24:20 GMTExelixis Earnings Call: Cabo Strength, Zanza Awaited - TipRanks
Fri, 07 Aug 2026 23:25:43 GMTOcugen: Buy Rating Reaffirmed as Cash Runway Extends to 2028 and Ophthalmology Pipeline Advances; $11 Price Target Maintained - TipRanks
Fri, 07 Aug 2026 18:01:20 GMTNatera Earns Buy Rating on Surging Signatera Demand, Raised Revenue Outlook, and Multi‑Year Growth Visibility - TipRanks
Fri, 07 Aug 2026 17:29:38 GMTCullinan Maintained at Buy as Rich Clinical Pipeline and Regulatory Momentum Support Unchanged $33 Price Target - TipRanks

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Regulatory Milestones Tipranks.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.